NeuroSense Therapeutics Other Current Assets

NeuroSense Therapeutics's other current assets stands at $580K as of December 2025. That compares with $860K in the prior-year period — down 32.7% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

NeuroSense Therapeutics reported $580K in other current assets versus $860K a year earlier — a 32.7% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $860K in the prior-year period — down 32.7% year over year. Sustained growth in other current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how NeuroSense Therapeutics's other current assets evolved across reporting periods, while the comparison chart places NRSN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.